Matches in SemOpenAlex for { <https://semopenalex.org/work/W2317506668> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W2317506668 endingPage "283" @default.
- W2317506668 startingPage "282.3" @default.
- W2317506668 abstract "<h3>Background</h3> White adipose tissue produces more than 50 adipokines and other molecules that participate through endocrine, paracrine, autocrine or juxtacrine mechanisms of action in a wide variety of physiopathological processes, including food intake, insulin sensitivity, vascular sclerotic processes, immunity and inflammation (1,2). Tumor necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS) is the most common autosomal dominant autoinflammatory disorder and is caused by mutations in the <i>TNFRSF1A</i> gene encoding the 55-kD receptor for TNF-α (TNFRSF1A) (3). <h3>Objectives</h3> the aims of our study were to evaluate serum leptin, resistin, visfatin and adiponectin levels in patients with tumor necrosis factor receptor-associated periodic syndrome (TRAPS), in comparison to healthy controls, and to correlate their levels to parameters of disease activity and/or severity. <h3>Methods</h3> serum leptin, resistin, visfatin and adiponectin levels were obtained from 14 TRAPS patients carrying mutations involving cysteine residues, from 16 TRAPS patients carrying other mutations, and from 16 healthy controls. Demographic, clinical and laboratory parameters, including amyloidosis were entered for each patient. Comparisons between groups as well as reciprocal comparisons have been evaluated. <h3>Results</h3> Serum leptin, resistin, visfatin and adiponectin did not significantly differ among the 3 groups. Serum leptin significantly correlated with the number of attacks/year (multiple R=0.32, multiple adjusted R<sup>2</sup>=0.19, p<0.03). Serum adiponectin levels significantly correlated with the presence of amyloidosis (multiple R=0.79, multiple adjusted R<sup>2</sup>=0.57, p<0.03). Adiponectin values were a significant predictor for amyloidosis (AUC 0.75, 95 CI: 0.56-0.94, p<0.03), with a predicting cut-off value set at 23.16 pg/ml, the predictive positive value was 53.8%. Visfatin serum levels resulted respectively related to leptin (r<sub>s</sub>=0.42, r<sup>2</sup>=0.18, p<0.02) and to resistin (r<sub>s</sub>=0.57, r<sup>2</sup>=0.32, p<0.01) serum levels; whilst leptin and resistin serum levels did not reciprocally correlate. <h3>Conclusions</h3> Although a prospective design study and larger cohort are mandatory, adipokines serum levels and their correlations with parameters of disease activity and/or severity, seem to show a baseline pattern in TRAPS patients. <h3>References</h3> Lago F, Dieguez C, Gόmez-Reino J, Gualillo O. Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol 2007;3:716-24. Cantarini L, Simonini G, Fioravanti A, et al.Circulating levels of the adipokines vaspin and omentin in patients with juvenile idiopathic arthritis, and relation to disease activity. Clin Exp Rheumatol 2011 [Epub ahead of print]. McDermott MF, Aksentijevich I, Galon J, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999; 97:133-44. <h3>Disclosure of Interest</h3> None Declared" @default.
- W2317506668 created "2016-06-24" @default.
- W2317506668 creator A5003774188 @default.
- W2317506668 creator A5014401271 @default.
- W2317506668 creator A5018403925 @default.
- W2317506668 creator A5023952807 @default.
- W2317506668 creator A5048971235 @default.
- W2317506668 creator A5054065266 @default.
- W2317506668 creator A5063656963 @default.
- W2317506668 creator A5066537123 @default.
- W2317506668 creator A5072181166 @default.
- W2317506668 creator A5085821633 @default.
- W2317506668 creator A5087775535 @default.
- W2317506668 date "2013-06-01" @default.
- W2317506668 modified "2023-09-24" @default.
- W2317506668 title "THU0376 Serum leptin, resistin, visfatin and adiponectin levels in tumor necrosis factor receptor-associated periodic syndrome (TRAPS)" @default.
- W2317506668 doi "https://doi.org/10.1136/annrheumdis-2012-eular.2341" @default.
- W2317506668 hasPublicationYear "2013" @default.
- W2317506668 type Work @default.
- W2317506668 sameAs 2317506668 @default.
- W2317506668 citedByCount "1" @default.
- W2317506668 countsByYear W23175066682020 @default.
- W2317506668 crossrefType "journal-article" @default.
- W2317506668 hasAuthorship W2317506668A5003774188 @default.
- W2317506668 hasAuthorship W2317506668A5014401271 @default.
- W2317506668 hasAuthorship W2317506668A5018403925 @default.
- W2317506668 hasAuthorship W2317506668A5023952807 @default.
- W2317506668 hasAuthorship W2317506668A5048971235 @default.
- W2317506668 hasAuthorship W2317506668A5054065266 @default.
- W2317506668 hasAuthorship W2317506668A5063656963 @default.
- W2317506668 hasAuthorship W2317506668A5066537123 @default.
- W2317506668 hasAuthorship W2317506668A5072181166 @default.
- W2317506668 hasAuthorship W2317506668A5085821633 @default.
- W2317506668 hasAuthorship W2317506668A5087775535 @default.
- W2317506668 hasConcept C126322002 @default.
- W2317506668 hasConcept C134018914 @default.
- W2317506668 hasConcept C171089720 @default.
- W2317506668 hasConcept C17991360 @default.
- W2317506668 hasConcept C194832188 @default.
- W2317506668 hasConcept C2776782570 @default.
- W2317506668 hasConcept C2777391703 @default.
- W2317506668 hasConcept C2779183219 @default.
- W2317506668 hasConcept C2779306644 @default.
- W2317506668 hasConcept C2779760629 @default.
- W2317506668 hasConcept C2780613262 @default.
- W2317506668 hasConcept C511355011 @default.
- W2317506668 hasConcept C71924100 @default.
- W2317506668 hasConceptScore W2317506668C126322002 @default.
- W2317506668 hasConceptScore W2317506668C134018914 @default.
- W2317506668 hasConceptScore W2317506668C171089720 @default.
- W2317506668 hasConceptScore W2317506668C17991360 @default.
- W2317506668 hasConceptScore W2317506668C194832188 @default.
- W2317506668 hasConceptScore W2317506668C2776782570 @default.
- W2317506668 hasConceptScore W2317506668C2777391703 @default.
- W2317506668 hasConceptScore W2317506668C2779183219 @default.
- W2317506668 hasConceptScore W2317506668C2779306644 @default.
- W2317506668 hasConceptScore W2317506668C2779760629 @default.
- W2317506668 hasConceptScore W2317506668C2780613262 @default.
- W2317506668 hasConceptScore W2317506668C511355011 @default.
- W2317506668 hasConceptScore W2317506668C71924100 @default.
- W2317506668 hasIssue "Suppl 3" @default.
- W2317506668 hasLocation W23175066681 @default.
- W2317506668 hasOpenAccess W2317506668 @default.
- W2317506668 hasPrimaryLocation W23175066681 @default.
- W2317506668 hasRelatedWork W1635539776 @default.
- W2317506668 hasRelatedWork W1968742439 @default.
- W2317506668 hasRelatedWork W1990354468 @default.
- W2317506668 hasRelatedWork W2000111212 @default.
- W2317506668 hasRelatedWork W2004793594 @default.
- W2317506668 hasRelatedWork W2037759202 @default.
- W2317506668 hasRelatedWork W2055081835 @default.
- W2317506668 hasRelatedWork W2064932444 @default.
- W2317506668 hasRelatedWork W2111780334 @default.
- W2317506668 hasRelatedWork W2111810762 @default.
- W2317506668 hasRelatedWork W2121327218 @default.
- W2317506668 hasRelatedWork W2130384790 @default.
- W2317506668 hasRelatedWork W2313333901 @default.
- W2317506668 hasRelatedWork W2320032781 @default.
- W2317506668 hasRelatedWork W2324019292 @default.
- W2317506668 hasRelatedWork W2408984397 @default.
- W2317506668 hasRelatedWork W2574781413 @default.
- W2317506668 hasRelatedWork W2890229961 @default.
- W2317506668 hasRelatedWork W2901991582 @default.
- W2317506668 hasRelatedWork W3131336803 @default.
- W2317506668 hasVolume "71" @default.
- W2317506668 isParatext "false" @default.
- W2317506668 isRetracted "false" @default.
- W2317506668 magId "2317506668" @default.
- W2317506668 workType "article" @default.